Compounds > b 31
Page last updated: 2024-12-07

b 31

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

B 31: has mitostatic action on mammalian cells; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID124689
SCHEMBL ID17394819
MeSH IDM0059783

Synonyms (6)

Synonym
b 31
60218-40-8
4,6-dimethyl-1-amino-3,4,5-trimethoxyphenylpyrimidine
4,6-dimethyl-n-(3,4,5-trimethoxyphenyl)-2-pyrimidinamine
DTXSID00208968
SCHEMBL17394819
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (20.00)18.2507
2000's0 (0.00)29.6817
2010's4 (80.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 79.30

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index79.30 (24.57)
Research Supply Index1.79 (2.92)
Research Growth Index4.32 (4.65)
Search Engine Demand Index131.61 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (79.30)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
SubstanceRelationship StrengthStudiesTrialsClassesRoles
uridine
[no description available]		1.9810uridinesdrug metabolite;
fundamental metabolite;
human metabolite
deoxyguanosine
[no description available]		1.9810purine 2'-deoxyribonucleoside;
purines 2'-deoxy-D-ribonucleoside		Escherichia coli metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
ConditionIndicatedRelationship StrengthStudiesTrials
Breast Cancer
[description not available]		03.0940
Breast Neoplasms
Tumors or cancer of the human BREAST.		03.0940
Local Neoplasm Recurrence
[description not available]		02.2110